GlycanAge
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
National Ageing Innovation Centre 3 The ...Website
www.glycanage.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About GlycanAge
GlycanAge is a leading biotech company specializing in glycobiology and the science of biological aging. With its innovative biological age test, GlycanAge is pioneering personalized preventative healthcare, enabling individuals to make informed decisions about their health and lifestyle.Explore more
GlycanAge Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GlycanAge your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on GlycanAge recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
GlycanAge, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if GlycanAge is spiking on competitors!
Check if GlycanAge has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once GlycanAge has new funding data
Product Launch: Get notified when GlycanAge launches new products
Click to see if GlycanAge had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at GlycanAge
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to GlycanAge
Compare insights from companies similar to GlycanAge, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GlycanAge is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
GlycanAge is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GlycanAge.
GlycanAge financials insights
Gather financial insights about GlycanAge, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$4.2M
2025
Unspecified
$8.7M
GlycanAge Tech Stack
A closer look at the technologies used by GlycanAge
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Sales, Digital Technology, Software, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology, Operations, Patient Experience, Telemedicine
Event
Product Marketing, Events, Sales, Digital Technology, Software, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology, Operations, Patient Experience, Telemedicine
Funding
Funding
Hiring Plans
GlycanAge has more open roles in Sales than it has had at any time in the past 12 months. Technologies mentioned include: HubSpot.
Hiring Plans
Funding
Funding
GlycanAge News & Media
Study Validates Glycans as Aging Biomarker and Finds Therapeutic Plasma Exchange Yields Greatest Reduction
Analysis of approximately 20,000 individuals across 42 studies establishes IgG glycans as independently predictive of all-cause mortality and shows aging can be measurably reversed by therapeutic plasma exchange (TPE) LONDON and SEATTLE, May 19, 2026 /PRNewswire/ -- GlycanAge, the leader...GlycanAge to Host Landmark Conference Focused on Practical Applications of Inflammaging Research
GlycanAge to Host Landmark Conference Focused on Practical Applications of Inflammaging ResearchUK longevity startup GlycanAge raises €7.4 million to bring glycan-based ageing ...
UK-based longevity startup GlycanAge has raised €7.4 million ($8.7 million) in fresh funding to accelerate the clinical development of its technology andGlycanAge Raises $4.2M in Seed Funding
GlycanAge, a London, UK-based biotech startup in the field of glycan biomarkers glycan biomarkers, raised $4.2M in Seed funding. The round was led by LAUNCHub Ventures and Kadmos Capital. The company intends to use the funds to expand operations and development efforts. Led by CEO Nikolina Lauc, GlycanAge is a biotech company specializing in glycobiology […] The post GlycanAge Raises $4.2M in Seed Funding appeared first on FinSMEs.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GlycanAge
Sign Up For FreeTo access detailed company insights
GlycanAge is a leading biotech company specializing in glycobiology and the science of biological aging. With its innovative biological age test, GlycanAge is pioneering personalized preventative healthcare, enabling individuals to make informed decisions about their health and lifestyle.... Read More
